MX2018009193A - Composición farmacéutica para prevenir o tratar nefropatía diabética. - Google Patents
Composición farmacéutica para prevenir o tratar nefropatía diabética.Info
- Publication number
- MX2018009193A MX2018009193A MX2018009193A MX2018009193A MX2018009193A MX 2018009193 A MX2018009193 A MX 2018009193A MX 2018009193 A MX2018009193 A MX 2018009193A MX 2018009193 A MX2018009193 A MX 2018009193A MX 2018009193 A MX2018009193 A MX 2018009193A
- Authority
- MX
- Mexico
- Prior art keywords
- diabetic nephropathy
- pharmaceutical composition
- preventing
- treating diabetic
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composición farmacéutica de la presente invención puede prevenir o tratar de forma eficaz nefropatía diabética al: bloquear, inhibir o retrasar, con antelación, el inicio de la nefropatía diabética; o aliviar la nefropatía diabética o inhibir el progreso de la nefropatía diabética.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2016/000898 WO2017131252A1 (ko) | 2016-01-27 | 2016-01-27 | 당뇨병성 신장질환의 예방 또는 치료용 약학적 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018009193A true MX2018009193A (es) | 2019-01-14 |
Family
ID=59398368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018009193A MX2018009193A (es) | 2016-01-27 | 2016-01-27 | Composición farmacéutica para prevenir o tratar nefropatía diabética. |
Country Status (6)
Country | Link |
---|---|
CO (1) | CO2018008145A2 (es) |
MX (1) | MX2018009193A (es) |
PH (1) | PH12018501570A1 (es) |
RU (1) | RU2702117C1 (es) |
SG (1) | SG11201806292QA (es) |
WO (1) | WO2017131252A1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050038093A1 (en) * | 2003-05-02 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Treating diabetic retinopathy with angiotensin II receptor blockers |
KR101810975B1 (ko) * | 2010-07-08 | 2017-12-20 | 에스케이바이오팜 주식회사 | 카바모일옥시 아릴알칸노일 아릴피페라진계 화합물을 포함하는 약학적 조성물 |
KR101414873B1 (ko) * | 2012-06-28 | 2014-07-03 | 보령제약 주식회사 | 피마살탄 및 히드로클로로티아지드가 함유된 약제학적 조성물 |
KR20150041223A (ko) * | 2013-10-04 | 2015-04-16 | 보령제약 주식회사 | 피마살탄을 포함하는 허혈성 뇌질환 예방 또는 치료용 약학적 조성물 |
-
2016
- 2016-01-27 SG SG11201806292QA patent/SG11201806292QA/en unknown
- 2016-01-27 RU RU2018130557A patent/RU2702117C1/ru active
- 2016-01-27 MX MX2018009193A patent/MX2018009193A/es unknown
- 2016-01-27 WO PCT/KR2016/000898 patent/WO2017131252A1/ko active Application Filing
-
2018
- 2018-07-24 PH PH12018501570A patent/PH12018501570A1/en unknown
- 2018-07-31 CO CONC2018/0008145A patent/CO2018008145A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017131252A1 (ko) | 2017-08-03 |
PH12018501570A1 (en) | 2019-04-15 |
SG11201806292QA (en) | 2018-08-30 |
CO2018008145A2 (es) | 2018-10-31 |
RU2702117C1 (ru) | 2019-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501999A1 (en) | K-ras modulators | |
EP3501527A4 (en) | COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER, CONTAINING A VESICLE DERIVED FROM BACTERIA OF A SPECIES ACTOBACILLUS | |
PH12018501009A1 (en) | Methods for treating conditions associated with masp-2 dependent complement activation | |
PH12015502091A1 (en) | Cdc7 inhibitors | |
MX2017014191A (es) | Metodos de tratamiento de una enfermedad neurodegenerativa. | |
GB2541571A (en) | Pharmaceutical compositions | |
WO2014164704A3 (en) | Compounds and compositions for the treatment of cancer | |
TW201713333A (en) | Methods of treating a neurodegenerative disease | |
PH12018550186A1 (en) | Pharmaceutical combinations for treating cancer | |
IL254169B (en) | A preparation for the prevention or treatment of valve calcification, containing a dpp-4 inhibitor | |
MX2017016114A (es) | Metodos para tratar o prevenir una proteopatia. | |
IL263697A (en) | Compounds, preparations and methods for the treatment and/or prevention of cancer | |
MX2021006326A (es) | Inhibidores de pcna. | |
MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
MX2018009662A (es) | Metodo y composicion farmaceutica para tratamiento de neurodegeneracion. | |
PH12018502318A1 (en) | Compositions and methods for treatment of inflammation of infection of the eye | |
EP3295946A4 (en) | Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy | |
IL269769B (en) | Mixtures, composition and their use for cancer treatment | |
PH12018501570A1 (en) | Pharmaceutical composition for preventing or treating diabetic nephropathy | |
IL282692A (en) | Compounds derived from madrasin, a preparation and their uses for the treatment of cancer | |
EP3710003A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR SELECTIVELY INHIBITING BETA-GLUCURONIDASES AND ATTENUATING SIDE EFFECTS ASSOCIATED WITH DIARRHEA CAUSED BY DRUG TREATMENT | |
MX2019001425A (es) | Composiciones y el uso de las mismas para el tratamiento o la prevención de la rosácea. | |
BR112017016596A2 (pt) | composição farmacêutica para prevenir ou tratar a leucemia mieloide crônica, e método de prevenção ou tratamento da leucemia mieloide crônica de um sujeito | |
GB2546703A (en) | Compounds | |
NZ730759A (en) | 1,2-benzothiazole compounds for the treatment of kidney disorders |